Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skin
- PMID: 26178975
- DOI: 10.1111/exd.12798
Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skin
Abstract
Cutaneous neurogenic inflammation (CNI) is frequently associated with skin disorders. CNI is not limited to the retrograde signalling of nociceptive sensory nerve endings but can instead be regarded as a multicellular phenomenon. Thus, soluble mediators participating in communication among sensory nerves, skin and immune cells are key components of CNI. These interactions induce the self-maintenance of CNI, promoting a vicious cycle. Certain G protein-coupled receptors (GPCRs) play a prominent role in these cell interactions and contribute to self-maintenance. Protease-activated receptors 2 and 4 (PAR-2 and PAR-4, respectively) and Mas-related G protein-coupled receptors (Mrgprs) are implicated in the synthesis and release of neuropeptides, proteases and soluble mediators from most cutaneous cells. Regulation of the expression and release of these mediators contributes to the vicious cycle of CNI. The authors propose certain hypothetical therapeutic options to interrupt this cycle, which might reduce skin symptoms and improve patient quality of life.
Keywords: PAR; inflammation; mrgpr; neurogenic; neurotransmitter; skin.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment in
-
Nociceptors in the skin: fire-raisers to be kept at bay?Exp Dermatol. 2015 Oct;24(10):732-3. doi: 10.1111/exd.12796. Epub 2015 Aug 21. Exp Dermatol. 2015. PMID: 26173654 No abstract available.
Similar articles
-
Nociceptors in the skin: fire-raisers to be kept at bay?Exp Dermatol. 2015 Oct;24(10):732-3. doi: 10.1111/exd.12796. Epub 2015 Aug 21. Exp Dermatol. 2015. PMID: 26173654 No abstract available.
-
Skin neurogenic inflammation.Semin Immunopathol. 2018 May;40(3):249-259. doi: 10.1007/s00281-018-0675-z. Epub 2018 Apr 30. Semin Immunopathol. 2018. PMID: 29713744 Free PMC article. Review.
-
Neuromediators--a crucial component of the skin immune system.J Dermatol Sci. 2002 Nov;30(2):87-93. doi: 10.1016/s0923-1811(02)00103-2. J Dermatol Sci. 2002. PMID: 12413763
-
Molecular Mechanisms of Neurogenic Inflammation of the Skin.Int J Mol Sci. 2023 Mar 5;24(5):5001. doi: 10.3390/ijms24055001. Int J Mol Sci. 2023. PMID: 36902434 Free PMC article. Review.
-
Neuroimmune interactions in allergic skin diseases.Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):365-73. doi: 10.1097/ACI.0b013e3282a644d2. Curr Opin Allergy Clin Immunol. 2007. PMID: 17873574 Review.
Cited by
-
Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.Br J Dermatol. 2019 May;180(5):1030-1038. doi: 10.1111/bjd.17455. Epub 2019 Jan 8. Br J Dermatol. 2019. PMID: 30623408 Free PMC article. Clinical Trial.
-
Pain in Atopic Dermatitis: An Online Population-based Survey.Acta Derm Venereol. 2020 Jul 2;100(14):adv00198. doi: 10.2340/00015555-3521. Acta Derm Venereol. 2020. PMID: 32424431 Free PMC article.
-
Neuropathic symptoms of the ocular surface: dryness, pain, and itch.Curr Opin Allergy Clin Immunol. 2017 Oct;17(5):373-381. doi: 10.1097/ACI.0000000000000389. Curr Opin Allergy Clin Immunol. 2017. PMID: 28858914 Free PMC article. Review.
-
In vitro and in vivo efficacy of the Active Oligo Skin complex™, a new active ingredient processed from seawater, on multiple parameters of atopic skin.Skin Health Dis. 2025 Feb 14;5(1):22-30. doi: 10.1093/skinhd/vzae029. eCollection 2025 Feb. Skin Health Dis. 2025. PMID: 40125013 Free PMC article.
-
Inhibitory Effect of Evodiamine on Psoriasis Lesions and Itching in Mice.Clin Cosmet Investig Dermatol. 2024 Jun 25;17:1527-1541. doi: 10.2147/CCID.S462446. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38948922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical